DEBORAH JEFFERSON: Open Payments
NPI 1033150644 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,636 in 29 payments from 9 companies in 2025. Trend: 2023 $324 · 2024 $293 · 2025 $1,636
Food & beverage: $978Travel & lodging: $658
| Company | Payments | Amount |
|---|---|---|
| CVRx, Inc. | 10 | $1,057 |
| PFIZER INC. | 4 | $192 |
| AstraZeneca Pharmaceuticals LP | 5 | $118 |
| E.R. Squibb & Sons, L.L.C. | 3 | $67 |
| BridgeBio Pharma, Inc. | 2 | $67 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $60 |
| Novo Nordisk Inc | 1 | $30 |
| Abbott Laboratories | 1 | $25 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
Products named: Barostim Neo System, VYNDAQEL, FARXIGA, CAMZYOS, Attruby, Kerendia, LOKELMA, Wegovy.
Industry payments across IL — which companies pay providers there.
